Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes
Ana Vieira, Yu Wan, Yan Ryan, Ho Kwong Li, Rebecca Guy, Maria Papangeli, Kristin K. Huse, Lucy C. Reeves, Valerie W. C. Soo, Roger Daniel, Alessandra Harley, Karen Broughton, Chenchal Dhami, M. Ganner, Marjorie Ganner, Zaynab Mumin, Maryam Razaei, Emma Rundberg, Rufat Mammadov, Ewurabena Mills, V. Sgrò, Kai Yi Mok, Xavier Didelot, Nicholas J. Croucher, Elita Jauneikaite, Theresa Lamagni, Colin Brown, Juliana Coelho, Shiranee Sriskandan
Abstract
Abstract The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1 UK to be the dominant source of invasive infections in this upsurge. Compared with ancestral M1 global strains, invasive M1 UK strains exhibit reduced genomic diversity and fewer mutations in two-component regulator genes covRS . The emergence of M1 UK is dated to 2008. Following a bottleneck coinciding with the COVID-19 pandemic, three emergent M1 UK clades underwent rapid nationwide expansion, despite lack of detection in previous years. All M1 UK isolates thus-far sequenced globally have a phylogenetic origin in the UK, with dispersal of the new clades in Europe. While waning immunity may promote streptococcal epidemics, the genetic features of M1 UK point to a fitness advantage in pathogenicity, and a striking ability to persist through population bottlenecks.